Search for: "Novo Nordisk, Inc."
Results 61 - 80
of 134
Sorted by Relevance
|
Sort by Date
10 Jun 2010, 3:58 am
(FDA Law Blog) Opana (Oxymorphone) - US: Impax Laboratories and Endo Pharmaceuticals settle pending litigation for Opana ER and announce development and co-promotion agreement (SmartBrief) (SmartBrief) (SmartBrief) Prandin (Repaglinide) – US: Patent infringement complaint following a Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent infringement suit filed in response to Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent infringement suit filed in response to Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent infringement suit filed in response to Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
29 Dec 2010, 2:57 am
Sandoz, Inc (IPBiz) (Patent Docs) Plavix (Clopidogrel) – Brazil: Superior Court of Justice denies Plavix patent extension (IP tango) Prandin (Repaglinide) – US: Novo Nordisk and Sandoz settle infringement claims in Prandin dispute (Patent Docs) Prandin (Repaglinide) – US: Supreme Court petitioned to review Federal Circuit patent use code decision: Caraco v Novo Nordisk (FDA Law Blog) [read post]
22 Apr 2010, 3:51 am
Teva (Orange Book Blog) (FDA Law Blog) Levistra (Vardenafil) – US: District Court Delaware: Patent infringement complaint following ANDA filing: Bayer Schering Pharma AG et al v Teva Pharmaceuticals USA, Inc et al (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for infringement of Nexavar patent before Delhi High Court (Spicy IP) Norfloxacin – Canada: Federal Court: Judgment in s 8 proceeding: Apotex v Merck (Pharmacapsules) Prandin (Repaglinide) – US:… [read post]
4 Jan 2013, 7:03 am
Novo Nordisk A/S, 132 S.Ct. 1670 (2012). 6. [read post]
18 Apr 2017, 4:34 pm
Novo Nordisk A/S, 108 F.3d 1361, 1365, 42 U.S.P.Q.2D (BNA) 1001, 1004 (Fed. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
7 Sep 2007, 4:59 am
Novo Nordisk A/S, 108 F.3d 1361, 1366 (Fed. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
29 Jun 2011, 5:59 am
Novo Nordisk A/S is a case involving a particular aspect of the Hatch-Waxman Act as pertaining to pharmaceutical approval. [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
30 Apr 2012, 8:03 am
Novo Nordisk A/S Martel v. [read post]
27 May 2011, 8:56 am
Novo Nordisk A/S . [read post]
8 Dec 2010, 2:20 am
– Nova Biomedical fight for survival following patent threats from Abbott, Roche, Medtronic (IP Directions) Pathogens and the Nagoya Protocol of the Convention on Biological Diversity (PatentlyBIOtech) Australia: Federal Court punishes CSL for amendment delay: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (Patentology) Australia: AusBiotech, legal academics and ARDR weigh in on gene patent debate (Patentology) Australia: Gene patent amendment bill introduced (IP… [read post]
15 Feb 2015, 9:13 pm
Novo Nordisk A/S v. [read post]
27 Apr 2010, 2:01 pm
Novo Nordisk A/S, 108 F.3d 1361, 1365 (Fed. [read post]
27 Jun 2011, 8:41 am
Amicus brief of Apotex, Inc. [read post]
23 Dec 2011, 6:30 am
Novo Nordisk A/S, and the Court will begin the new year with Kappos v. [read post]
